Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Reductions in World Health Organization Risk Drinking Levels as a Primary Efficacy End Point for Alcohol Clinical Trials: A Review.
Journal: JAMA psychiatry
Published: September 17, 2025
Insulin and glucose metabolism with olanzapine and a combination of olanzapine and samidorphan: exploratory phase 1 results in healthy volunteers.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Published: June 04, 2021
An Evidence-Based Review of OLZ/SAM for Treatment of Adults with Schizophrenia or Bipolar I Disorder.
Journal: Neuropsychiatric disease and treatment
Published: April 01, 2021
A phase 3, multicenter study to assess the 1-year safety and tolerability of a combination of olanzapine and samidorphan in patients with schizophrenia: Results from the ENLIGHTEN-2 long-term extension.
Journal: Schizophrenia research
Published: September 09, 2020
Effects of Olanzapine Combined With Samidorphan on Weight Gain in Schizophrenia: A 24-Week Phase 3 Study.
Journal: The American journal of psychiatry
Published: August 15, 2020
Reply to Kunoe (2020) and Ghosh & Singh (2020) regarding Nunes et al. (2020): Opioid use and dropout from extended-release naltrexone in a controlled trial: implications for mechanism.
Journal: Addiction (Abingdon, England)
Published: May 29, 2020
Transition of Patients with Opioid Use Disorder from Buprenorphine to Extended-Release Naltrexone: A Randomized Clinical Trial Assessing Two Transition Regimens.
Journal: The American journal on addictions
Published: October 04, 2019
Mitigation of Olanzapine-Induced Weight Gain With Samidorphan, an Opioid Antagonist: A Randomized Double-Blind Phase 2 Study in Patients With Schizophrenia.
Journal: The American journal of psychiatry
Published: March 09, 2019
Olanzapine Plus Samidorphan (ALKS 3831) in Schizophrenia and Comorbid Alcohol Use Disorder: A Phase 2, Randomized Clinical Trial.
Journal: The Journal of clinical psychiatry
Published: February 13, 2019
Efficacy and Safety of a Combination of Olanzapine and Samidorphan in Adult Patients With an Acute Exacerbation of Schizophrenia: Outcomes From the Randomized, Phase 3 ENLIGHTEN-1 Study.
Journal: The Journal of clinical psychiatry
Published: February 05, 2019
Opioid use and dropout from extended-release naltrexone in a controlled trial: implications for mechanism.
Journal: Addiction (Abingdon, England)
Published: August 03, 2018
Last Updated: 09/26/2026